231 related articles for article (PubMed ID: 29958221)
21. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
22. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
Fan Z; George AL; Kyle JW; Makielski JC
J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
[TBL] [Abstract][Full Text] [Related]
23. Lidocaine reduces the transition to slow inactivation in Na(v)1.7 voltage-gated sodium channels.
Sheets PL; Jarecki BW; Cummins TR
Br J Pharmacol; 2011 Sep; 164(2b):719-30. PubMed ID: 21232038
[TBL] [Abstract][Full Text] [Related]
24. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine.
Chevrier P; Vijayaragavan K; Chahine M
Br J Pharmacol; 2004 Jun; 142(3):576-84. PubMed ID: 15148257
[TBL] [Abstract][Full Text] [Related]
25. Isoform-specific lidocaine block of sodium channels explained by differences in gating.
Nuss HB; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
Biophys J; 2000 Jan; 78(1):200-10. PubMed ID: 10620286
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
27. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
[TBL] [Abstract][Full Text] [Related]
28. The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.
Schulze V; Stoetzer C; O'Reilly AO; Eberhardt E; Foadi N; Ahrens J; Wegner F; Lampert A; de la Roche J; Leffler A
Br J Pharmacol; 2014 Jan; 171(2):427-37. PubMed ID: 24117196
[TBL] [Abstract][Full Text] [Related]
29. The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels.
Vedantham V; Cannon SC
J Gen Physiol; 1999 Jan; 113(1):7-16. PubMed ID: 9874684
[TBL] [Abstract][Full Text] [Related]
30. The effects of A-803467 on cardiac Nav1.5 channels.
Han Z; Jiang Y; Xiao F; Cao K; Wang DW
Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
[TBL] [Abstract][Full Text] [Related]
31. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
Ragsdale DS; Scheuer T; Catterall WA
Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
[TBL] [Abstract][Full Text] [Related]
32. Local anesthetics block transient outward potassium currents in rat neocortical neurons.
Andreasen M; Hablitz JJ
J Neurophysiol; 1993 Jun; 69(6):1966-75. PubMed ID: 8394410
[TBL] [Abstract][Full Text] [Related]
33. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp.
Penniman JR; Kim DC; Salata JJ; Imredy JP
J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018
[TBL] [Abstract][Full Text] [Related]
34. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat.
Wang CF; Gerner P; Schmidt B; Xu ZZ; Nau C; Wang SY; Ji RR; Wang GK
Anesth Analg; 2008 Oct; 107(4):1397-405. PubMed ID: 18806059
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
Foadi N; Berger C; Pilawski I; Stoetzer C; Karst M; Haeseler G; Wegner F; Leffler A; Ahrens J
Anesth Analg; 2014 Jun; 118(6):1238-45. PubMed ID: 24755846
[TBL] [Abstract][Full Text] [Related]
36. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
[TBL] [Abstract][Full Text] [Related]
37. Benzonatate inhibition of voltage-gated sodium currents.
Evans MS; Maglinger GB; Fletcher AM; Johnson SR
Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
[TBL] [Abstract][Full Text] [Related]
38. Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists.
Van't Klooster MP; Foadi N; Hage A; Stoetzer C; Wegner F; Eberhardt M; Leffler A
Eur J Pharmacol; 2016 Oct; 789():119-126. PubMed ID: 27401036
[TBL] [Abstract][Full Text] [Related]
39. A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation.
Horne AJ; Eldstrom J; Sanatani S; Fedida D
Heart Rhythm; 2011 May; 8(5):770-7. PubMed ID: 21193062
[TBL] [Abstract][Full Text] [Related]
40. Cationic Modulation of Voltage-Gated Sodium Channel (Nav1.5): Neonatal Versus Adult Splice Variants-2. Divalent (Cd
Onkal R; Fraser SP; Djamgoz MBA
Bioelectricity; 2019 Sep; 1(3):148-157. PubMed ID: 34471817
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
